Anyone who has a steady stream on income knows that investing in stocks can be one of the most rewarding things you can do as long you're looking at the right places. However, gaining the right knowledge to invest skillfully takes time and patience, and a lot of reading up on certain industries. Now that Donald Trump has been voted as our President-elect, one of the more interesting industries to begin looking into is the health sector. There are a plethora of companies in this sector ranging from large companies like UnitedHealth Group Inc. (NYSE:UNH), to smaller and mid-size companies like Allied Healthcare Products, Inc. (NASDAQ:AHPI), or Progressive Care, Inc. (OTCQB:RXMD), that can help in diversifying your portfolio to increase your returns.
UnitedHealth Group Inc. is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. Recently, UNH launched new value-based care payment to help improve health outcomes and reduce costs for knee, hip and spine procedures. From the period of November 4 to December 2, the company's share price saw an increase of 18% and it seems that they will be following this trend following its current dip.
Allied Healthcare Products, Inc. is a company that manufactures a range of respiratory products used in the healthcare industry in a range of hospital and alternate site settings, including sub-acute care facilities, home healthcare and emergency medical care. The company's products are used in the treatment of acute and chronic respiratory disorders such as asthma, emphysema, bronchitis and pneumonia. Since seeing lows on November 23, the company's share price has increased by 138%.
Progressive Care, Inc. through its subsidiary PharmCo, LLC (PharmCo), is a health services company. The Company is engaged in providing prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities. RXMD recently increased their revenue by 33% to $1.6 million, a record for the quarter for the company. From the period of November 11 to November 22, the share price of the company saw an increase of 36% and it looks like the company is set up to repeat the same pattern.